Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tevogen Bio Holdings Inc. - Common Stock (NQ:TVGN)

1.230 -0.010 (-0.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tevogen Bio Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Is Small-Cap Tevogen Bio Stock Rocketing Higher On Thursday?
evogen Bio projects strong revenue for its oncology pipeline and reports positive phase 1 trial data for its COVID-19 therapy. The company's stock is trading higher amid increased volume. 
Via Benzinga
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Investors Congratulate on Prestigious Recognition of Pioneering Biopharma Business Model, Breakthrough Innovations, Building Assets Estimated to Exceed $10 Billion
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Thanks Warren Township for Proclamation Honoring CEO Dr. Ryan Saadi, Nobel Peace Prize Nomination, and the Company's Mission to Address Health Inequality
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Tevogen Bio Takes Lead in Developing Cell Therapies Designed to Eradicate Post Procedure Human Papilloma Virus in Women with Precancerous Cervical Lesions
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Highlights the Publication of Promising Trial Data as the CEO Expresses Optimism About the Company’s Scientific Breakthrough in Mainstreaming Cell Therapy Through a New Class of Off-the-Shelf T-Cell Therapies, Manufactured and Stored for
From Tevogen Bio Inc
Via GlobeNewswire
Why Ericsson Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Tevogen CEO Reaffirms the Company’s Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue Projections
From Tevogen Bio Inc
Via GlobeNewswire
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Crude Oil Down Over 2%; Verb Technology Shares Spike Higher
Via Benzinga
Leaders in The News: BigBear.ai, Luminar, New World Solutions, Tevogen Bio
Latest Advances in AI for Military, Biotech, Electric Vehicles and Digital Transformation of $31 Billion Watch Market 
Via News Direct
Topics Artificial Intelligence
Nasdaq Surges 1%; Boeing Reports 10% Workforce Reduction
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 47%; Here Are 20 Stocks Moving Premarket
Via Benzinga
A Lot Of Home Runs And One Ugly Strikeout; One New Swing Position
In this video, I review some amazing trades, one missed entry non-trade, a losing trade, and how not taking a high conviction trade can ruin them all. 
Via Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Tevogen Bio Plans to Share $1B+ Revenue Potential of its Pipeline Portfolio Beginning Week of October 14, 2024
From Tevogen Bio Inc
Via GlobeNewswire
Tevogen Bio Extends Pipeline Prioritizing Oncology and Long COVID
From Tevogen Bio Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Tevogen Bio Highlights Promising Trial Data as CEO Leads Patient Advocacy at Capitol Hill, Pledging to Leverage Multi-Billion Dollar Company Assets to Combat Long COVID and Spearhead a New Wave of Medical Innovation
From Tevogen Bio Inc
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.